🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
Concurrent chemoradiotherapy has been demonstrated a significant improvemen...
Status
Unknown
Location
Zhongnan Hospital of Wuhan University
Start Date
2013-05
Trial ID
NCT01889303
Treatments Being Tested
The standard treatment of local advanced cervical cancer is concurrent chem...
Status
Unknown
Location
Xijing hospital, the Fourth Military Medical University
Start Date
2016-02
Trial ID
NCT02703961
To determine the efficacy and safety of sequential chemoradiotherapy with r...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2010-01
Trial ID
NCT03389295
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2000-06-07
Trial ID
NCT00544414
Previous studies have suggested that immunotherapy combined with chemothera...
Status
Unknown
Location
Hunan Cancer hospital
Start Date
2022-11-25
Trial ID
NCT05430906
Treatments Being Tested
Patients enrolled for the study, who are eligible for NACT, will undergo a ...
Status
Unknown
Location
HealthCare Global Enterprises Ltd
Start Date
2016-04
Trial ID
NCT02985255
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
The purpose of this study is to determine whether a combination of the drug...
Status
Completed
Location
Memorial Sloan-Kettering at Basking Ridge
Start Date
2008-05
Trial ID
NCT00675597
Treatments Being Tested
Most ESCC received NAC in China without supportive evidence from local RCTs...
Status
Completed
Location
Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzhou University)
Start Date
2021-01-01
Trial ID
NCT05569668
Treatments Being Tested